October 20, 2025

Get In Touch

Chemists Directed To Share Information On Cough, Cold Drug Buyers In MP

Bhopal: In a bid to curb Covid cases, all the chemists have been directed to upload information on the people who seek medications for cold, cough, fever or difficulty in breathing on the government's Sarthak Lite app.
The move aims at tracing down symptoms of Covid-19 in individuals.
The Sarthak app is Madhya Pradesh government's mobile-based application designed and developed to keep track of COVID-19 patients
The direction has come from the district administration, wherein, all the medical stores have been asked to compile information about the individuals who could be suffering from symptoms of Covid-19.
Also Read: Covid Recovery Rate In MP At 90.55 Percent: Dr Harsh Vardhan
Sarthak Lite app or the link addess: http:// fda.mponline-.gov.in. such information provided by the medical stores, as informed by Chief medical & Health Officer to TOI.
He also directed the chemists to download the link or the app to start furnishing the relevant information about suspected covid-19 patients visiting medical stores for medicines and complaining of symptoms of the virus.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!